Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy

Anticancer Research

Volumn 20, Issue 6 C, 2000, Pages 4777-4783

  Tsavaris, N ^a   Kosmas, C ^a   Mylonakis, N ^a   Bacoyiannis, C ^a   Kalergis, G ^a   Vadiaka, M ^a   Boulamatsis, D ^a   Iakovidis, V ^a   Kosmidis, P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Antiemetic; Chemotherapy; Cisplatin; Emesis; Nausea

Indexed keywords

CISPLATIN; ONDANSETRON;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RATING SCALE; STRESS; TREATMENT OUTCOME; TUMOR LOCALIZATION; VOMITING;

ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANXIETY; CISPLATIN; DEPRESSION; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; ONDANSETRON; PROBABILITY; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; VOMITING; WEIGHT LOSS;

EID: 0034494862     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Methodology in anti-emetic trials
2. Methodology in antiemetic trials
3. Methodology of antiemetic trials: A review
4. Antiemetic Studies: A methodological discussion
5. Mechanisms and management of nausea and emesis
6. Factors that influence the antiemetic activity of metoclopramide to cisplatin based chemtherapy
7. Antiemetic study methodology: Recommendations for future studies
8. The assessment of nausea and vomiting. Past problems, current issues and suggestions for future research
9. Anticipatory nausea and/or vomiting
10. Antiemetic effect of deHa-9-trahydrocannabinol in patients receiving cancer chemotherapy
11. Social psychologic factors affecting the presentation of bodily complaints
12. Social support, accommodation to stress and adjustment to breast cancer
13. Comparison of Ondansentron (GR 38032F) vs Ondansentron plus Methylprednizolone as antiemetic prophylaxis during cisplatin containing chemotherapy
14. Comparison of Ondansentron (GR 38032F) vs Ondansentron plus Alprazolam as antiemetic prophylaxis during cisplatin containing chemotherapy
15. Comparison of different schedules of Ondansentron (GR 38032 F) administration during cisplatin based chemotherapy
16. The influence of ondasentron and metoclopramide on electrolyte inbalance in patients with nausea and vomiting receiving cisplatin based chemotherapy
17. Efficacy of Ondansentron treatment with different timing schedules. A randomized double plind study
18. A randomized comparative study of antiemetic prophylaxis with ondansentron in a single 32 mg loading dose vs 8 mg every 6 hours, in patients undergoing cisplatin - Based chemotherapy
19. Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin
20. Comparison of antiemetic activity of chloropromazine and high doses of metoclopramide in cisplatin based chemotherapy
21. Antiemetic efficacy of high dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy. A randomized study
22. Methodology of antiemetic trials: A review
23. Reporting resuHs of cancer treatment
24. Approaches to management of emesis
25. The assessment of anxiety states by rating
26. Social readjustment rating scale
27. On the contributiol of independent two sample test of Wilcoxon
28. Ondansentron compared with high dose metoclopramide in prophylaxis of acute and delayed cisplatin induced nausea and vomiting
29. Delta-9-tetrahydrocanabinol in cancer chemotherapy: Research problems and issues
30. The epidemiologic evidence for a relationship between social support and health